Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Women with PCOS tend to be less optimistic than those without it.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Finasteride can cause side effects, some lasting after treatment ends, and may lead to severe depression or suicidal thoughts.

Depression and hair loss may influence each other.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

Increasing TSPO in the brain reduces anxiety and depression.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

Finasteride (Propecia) may cause depression and suicidal thoughts; stop use and inform a healthcare professional if symptoms develop.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.